•
Mar 31, 2024

REGENXBIO Q1 2024 Earnings Report

Total Revenue
$15.6M
Previous year: $19.1M
-18.4%
EPS
-$1.38
Previous year: -$1.53
-9.8%
Gross Profit
$7.16M
Previous year: $15M
-52.4%
Cash and Equivalents
$339M
Previous year: $70.1M
+383.2%
Free Cash Flow
-$56M
Previous year: -$85.7M
-34.7%
Total Assets
$629M
Previous year: $748M
-15.9%

REGENXBIO

REGENXBIO